Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Fawzi, US
Ahmad Fawzi, Bellevue, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090197967 | COMPOSITIONS AND METHODS FOR TREATMENT OF OPHTHALMIC DISEASES AND DISORDERS - Provided herein are compositions and methods for treating ophthalmic diseases and disorders. Compositions comprising retinylamine derivative compounds provided herein are useful for treating and preventing ophthalmic diseases and disorders, including diabetic retinopathy diabetic maculopathy, diabetic macular edema, retinal ischemia, ischemia-reperfusion related retinal injury, and metabolic optic neuropathy. | 08-06-2009 |
Amani Fawzi, Los Angeles, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090030323 | Ultrasound and Microbubbles in Ocular Diagnostics and Therapies - The present disclosure described methods, systems, and techniques for applying contrast-enhanced ultrasound to locate areas of blockage within retinal vessels and to break up clots that are causing damage. In addition to identifying the damaged area, the researchers anticipate that the initial image may serve as a baseline for monitoring the effect of treatment on the vessel, which may be achieved in multiple ways. The vibration effect of the ultrasound itself may suffice to dislodge clots. The microbubbles may also be coated or filled with medication, with ultrasonic shock waves activating the coating or causing mini explosions to release the medicine. Loading the microbubbles with a therapeutic agent, visualizing their presence at the diseased site using the ultrasound diagnostic mode, and then activating the microbubbles to release their contents at the targeted lesion could be a powerful and effective way to reverse occlusion without harming other areas of the eye or body. | 01-29-2009 |
Khaled M. Fawzi, San Jose, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090080113 | Vision guided system and method for micro-scale flex cable/integrated lead suspension solder pad positioning in HDD assembling process - An apparatus for positioning a component relative to an associated component. The apparatus includes a component receiver and onto which the component is disposed. The apparatus also includes an associated component receiver and onto which the associated component is disposed. The component receiver orients the component into a position for retaining the component to the associated component. The apparatus further includes a retention device driver for inserting a retention device, the retention device retaining the component to the associated component in the position. The apparatus also includes an optical position verifier for verifying the position of the component and the associated component. | 03-26-2009 |
| 20090158574 | Ganged removal of hard disk drive cover screws - An apparatus for removal of retentive mechanisms retaining a cover of a component device. The apparatus includes a structure. The apparatus also includes a component device positioner coupled to the structure. The apparatus additionally includes a plurality of retentive mechanism removers coupled with the structure. Each of the plurality of retentive mechanism removers are configured for interoperability with each retention mechanism retaining a cover of a component device having a plurality of retention mechanisms disposed therein. The apparatus further includes a drive mechanism that is coupled with the structure. The drive mechanism is for rotation of each of the plurality of retentive mechanism removers, causing removal of each retention mechanism retaining the cover of the component device. | 06-25-2009 |
Mahdi B. Fawzi, Morristown, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080214507 | MONO-AND-DI-PHOSPHATES OF 3-(3-FLUORO-4-HYDROXY-PHENYL)-7-HYDROXY-NAPHTHALENE-1-CARBONITRILE - Compounds of formula II | 09-04-2008 |
| 20090137559 | BAZEDOXIFENE ASCORBATE - The present invention is directed to bazedoxifene ascorbate, compositions containing the same, dispersions thereof, preparations thereof, and uses thereof. | 05-28-2009 |
| 20100221445 | O-DESMETHYLVENLAFAXINE AND BAZEDOXIFENE COMBINATION PRODUCT AND USES THEREOF - A combination product containing at least two active compounds, O-desmethylvenlafaxine or a pharmaceutically acceptable salt thereof and bazedoxifene or a pharmaceutically acceptable salt thereof is described. Also described are methods of making and using this combination product to treat a variety of conditions associated with low circulating estrogen levels or low estrogen receptor activity. | 09-02-2010 |
| 20100249169 | FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOF - The present invention provides formulations that achieve effective delivery of methylnaltrexone compositions. The provided formulations are useful for preventing, treating delaying, diminishing or reducing the severity of side effects resulting from use of analgesic opioids. | 09-30-2010 |
| 20110118216 | Tigecycline Compositions and Methods of Preparation - The present invention relates to novel tigecycline compositions with improved stability in both solid and solution states and processes for making these compositions. These compositions comprise tigecycline, a suitable carbohydrate, and an acid or buffer. | 05-19-2011 |
Mahdi Bakir Fawzi, Morristown, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090176720 | COMPOSITIONS CONTAINING PIPERACILLIN AND TAZOBACTAM USEFUL FOR INJECTION - An aminocarboxylic acid chelating agent, preferably EDTA, or a salt thereof has been found to be useful for inhibiting particulate formation in piperacillin/tazobactam parenteral combinations. The composition may also contain a buffer, preferably citrate, and optionally an aminoglycoside. The product may be in the form of a frozen composition that can be thawed for use. The product may also be in the form of a cryodesiccated powder that can be reconstituted by addition of an aqueous vehicle to reform a solution. | 07-09-2009 |
| 20100035845 | TIGECYCLINE FORMULATIONS - The invention is directed to a frozen pharmaceutical formulation suitable for administration to a subject parenterally, comprising a therapeutically effective amount of tigecycline and an agent selected from the group consisting of lactose, dextrose, glucose, mannose, sucrose, ribose, xylose and a combination thereof, wherein the formulation in a pre-frozen state at about 22° C. or in an unfrozen state at about 22° C. has a pH in the range of from 4.0 to 5.5. Preferably, the formulation is suitable for storage at or below about −20° C. over a period of at least about 2 months, preferably 6 months, more preferably 26 months. Alternatively, the formulation is suitable for storage at about 22° C. over a period of about 24 hours. | 02-11-2010 |
| 20110166091 | Compositions Containing Piperacillin and Tazobactam Useful for Injection - An aminocarboxylic acid chelating agent, preferably EDTA, or a salt thereof has been found to be useful for inhibiting particulate formation in piperacillin/tazobactam parenteral combinations. The composition may also contain a buffer, preferably citrate, and optionally an aminoglycoside. The product may be in the form of a frozen composition that can be thawed for use. The product may also be in the form of a cryodesiccated powder that can be reconstituted by addition of an aqueous vehicle to reform a solution. | 07-07-2011 |
Natalie V. Fawzi, Belmont, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090299462 | ENDOVASCULAR GRAFT INCLUDING SUBSTRUCTURE FOR POSITIONING AND SEALING WITHIN VASCULATURE - An endovascular graft having an improved positioning mechanism capable of positioning and securing a bifurcated graft into a bifurcated vessel described. The graft can include a sleeve affixed to graft that is used in combination with a contralateral wire loop for placement of the graft within vasculature. The graft may include a structure for post deployment positioning into the bifurcated aneurysm area. Furthermore, the endovascular graft may be configured to form a sealing pocket that expands with induced fluid pressure and prevents fluid leaks at an attachment site. | 12-03-2009 |
| 20100234726 | DEVICE AND METHOD FOR SAFE LOCATION AND MARKING OF A BIOPSY CAVITY - Cavity and sentinel lymph node marking | 09-16-2010 |